Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioForce Nanosciences HoldingsBFNH +4.65%32 3-Year EBITDA Growth Rate is 4.10% as of Jun. 2026. GuruFocus rates BFNH with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,660 Consumer Packaged Goods companies, BioForce Nanosciences Holdings ranks worse than 58.31% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 4.10% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 60.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioForce Nanosciences Holdings was 89.00% per year. The lowest was -1593.60% per year. And the median was 0.00% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
BioForce Nanosciences Holdings 3-Year EBITDA Growth Rate Related Terms
BFNH vs BHST, LSF, HAIN: 3-Year EBITDA Growth Rate Comparison
For the Packaged Foods subindustry, BioForce Nanosciences Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioForce Nanosciences Holdings 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where BioForce Nanosciences Holdings's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 4.10% mean?
BioForce Nanosciences Holdings (BFNH) has a 3-Year EBITDA Growth Rate of 4.10% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for BioForce Nanosciences Holdings and its competitors. According to the industry distribution chart, BioForce Nanosciences Holdings ranks #968 out of 1660 companies in the Consumer Packaged Goods industry, placing it in the top 58.3%.
Is BioForce Nanosciences Holdings' 3-Year EBITDA Growth Rate too high?
BioForce Nanosciences Holdings' current 3-Year EBITDA Growth Rate is 4.10%. The Consumer Packaged Goods industry median 3-Year EBITDA Growth Rate is 8.00. BioForce Nanosciences Holdings' value of 4.10% is 48.8% below this industry median. Based on the distribution chart, BioForce Nanosciences Holdings ranks #968 out of 1660 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, BioForce Nanosciences Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' 3-Year EBITDA Growth Rate compare to BHST and LSF?
According to the Consumer Packaged Goods industry distribution chart, BioForce Nanosciences Holdings ranks #968 out of 1660 companies for 3-Year EBITDA Growth Rate. This places BioForce Nanosciences Holdings in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.00. BioForce Nanosciences Holdings' value of 4.10% is 48.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.00, based on 1,660 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioForce Nanosciences Holdings's current 3-Year EBITDA Growth Rate of 4.10% is 48.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for BioForce Nanosciences Holdings and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioForce Nanosciences Holdings's current 3-Year EBITDA Growth Rate is 4.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current 3-Year EBITDA Growth Rate of 4.10%. The current 3-Year EBITDA Growth Rate is 4.10% and 48.8% below the Consumer Packaged Goods industry median of 8.00. BioForce Nanosciences Holdings' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current 3-Year EBITDA Growth Rate is 4.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
32GF Score
Get the complete analysis for BFNH
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFNH has been successfully added to your 
